Cargando…
Attitudes toward clinical trials across the Alzheimer’s disease spectrum
BACKGROUND: Research has revealed that manifest Alzheimer’s disease (AD) dementia is preceded by preclinical and prodromal phases during which pathology is accumulating but function remains intact. This understanding and concern that disease-modifying interventions initiated at the dementia stage ma...
Autores principales: | Nuño, Michelle M., Gillen, Daniel L., Dosanjh, Kulwant K., Brook, Jenny, Elashoff, David, Ringman, John M., Grill, Joshua D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628443/ https://www.ncbi.nlm.nih.gov/pubmed/28978335 http://dx.doi.org/10.1186/s13195-017-0311-5 |
Ejemplares similares
-
Study partner types and prediction of cognitive performance: implications to preclinical Alzheimer’s trials
por: Nuño, Michelle M., et al.
Publicado: (2019) -
Recruitment across two decades of NIH-funded Alzheimer’s disease clinical trials
por: Ritchie, Marina, et al.
Publicado: (2023) -
A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer’s disease
por: Grill, Joshua D., et al.
Publicado: (2015) -
Recruitment and retention of participant and study partner dyads in two multinational Alzheimer’s disease registration trials
por: Bernstein, Olivia M., et al.
Publicado: (2021) -
Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials
por: Ritchie, Marina, et al.
Publicado: (2023)